Target for next week : 8%
New feat achieved by Eurobio Scientific, which announced Wednesday evening to have obtained the CE marking for its test against the coronavirus, which allows a result 1h15 after extraction. The laboratory specializing in in vitro diagnostics says it can triple its current capacity according to demand. The title takes off on the Paris Stock Exchange.
With the sale of NOVAPrep, we should be able to target € 0.637 (i.e. + 243%).
Novacyt has been falling linearly since April 2016 (purchase of Primer Design). If it continues on this trend then it should go out 0.01 € towards end of October 2019.
Gaps are areas on a chart where the price of a stock moves sharply up or down, with little or no trading in between.
Profitability will be announced in January for the first time.
The gap is closed ! I bought back at $334.41 New target: $390
Our target before EOY is €9 (~ $10).
TSLA will close the GAP at $335.5 and we can put the new target at $360.